Search hospitals > Missouri > Springfield
Clinvest Research LLC
Claim this profileSpringfield, Missouri 65807
Global Leader in Migraine
Global Leader in Headache
Conducts research for Arthritis
Conducts research for Diabetes
Conducts research for Type 2 Diabetes
142 reported clinical trials
3 medical researchers
Summary
Clinvest Research LLC is a medical facility located in Springfield, Missouri. This center is recognized for care of Migraine, Headache, Arthritis, Diabetes, Type 2 Diabetes and other specialties. Clinvest Research LLC is involved with conducting 142 clinical trials across 64 conditions. There are 3 research doctors associated with this hospital, such as David Gregory True, David True, MD, and Ralph Joseph Duda.Top PIs
David Gregory TrueClinvest Research LLC1 year of reported clinical research
Studies Neuralgia
Studies Diabetic Neuropathy
23 reported clinical trials
25 drugs studied
David True, MDClinvest Research LLC1 year of reported clinical research
Studies Migraine
Studies Obesity
14 reported clinical trials
15 drugs studied
Ralph Joseph DudaClinvest Research LLC1 year of reported clinical research
Studies Diabetes
Studies Type 2 Diabetes
4 reported clinical trials
4 drugs studied
Clinical Trials running at Clinvest Research LLC
Migraine
Obesity
Cardiovascular Disease
Type 2 Diabetes
Osteoarthritis
Rheumatoid Arthritis
Diabetes
Arthritis
Obstructive Sleep Apnea
Neuralgia
Eptinezumab
for Migraine
Medication overuse headache (MOH) is a type of headache caused by excessive use of acute headache or migraine medications (medications used to treat a headache or migraine once it begins). Treatment of MOH usually involves reducing the dose of or discontinuing acute medications. Eptinezumab is a medication used for the preventive treatment of migraine in adults. The main goals of this trial are to learn whether eptinezumab helps reduce the number of days with migraine, the number of days with headache, and acute medication use in adults who have migraine and MOH.
Recruiting3 awards Phase 44 criteria
Rimegepant
for Migraine
This study is being conducted to evaluate the efficacy and tolerability of rimegepant in a population of adults that are unsuitable for triptan medications due to a previous intolerance, lack of efficacy, or contraindication (including a history of clinically-relevant cardiovascular disease).
Recruiting2 awards Phase 4
Rimegepant
for Migraine Prevention
This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate response to oral preventive medications
Recruiting2 awards Phase 41 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Clinvest Research LLC?
Clinvest Research LLC is a medical facility located in Springfield, Missouri. This center is recognized for care of Migraine, Headache, Arthritis, Diabetes, Type 2 Diabetes and other specialties. Clinvest Research LLC is involved with conducting 142 clinical trials across 64 conditions. There are 3 research doctors associated with this hospital, such as David Gregory True, David True, MD, and Ralph Joseph Duda.